MEDREICH CO-AMOXICLAV 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablets blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

potassium clavulanate, Quantity: 148.875 mg; amoxicillin trihydrate, Quantity: 1006.25 mg

Disponible des:

Medreich Australia Pty Ltd

Designació comuna internacional (DCI):

amoxicillin trihydrate,potassium clavulanate

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: ethylcellulose; isopropyl alcohol; microcrystalline cellulose; purified talc; dichloromethane; magnesium stearate; propylene glycol; croscarmellose sodium; hypromellose; titanium dioxide; hyprolose; industrial methylated spirit

Vía de administración:

Oral

Unidades en paquete:

2, 10, 60

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

MEDREICH CO-AMOXICLAV 500/125 and MEDREICH CO-AMOXICLAV 875/125 tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology):,Urinary Tract Infections (uncomplicated and complicated),Lower Respiratory Tract Infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,Upper Respiratory Tract Infections, such as sinusitis, otitis media and recurrent tonsillitis.,Skin and Skin Structure Infection,Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Amoxicillin and clavulanic acid tablets. However, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate.,The treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to Amoxicillin and clavulanic acid tablets should not require the addition of another antibiotic due to the amoxicillin content of these products.

Resumen del producto:

Visual Identification: A white elongated capsule shaped film coated tablet.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2017-01-17